Table 2 Mean scores at 15-month follow-up for mean outcome variables and total costs (in euros) per patient per treatment group

QBPDS^b

40.42 (22.34)

38.19 (20.84)

−2.23 (-13.20 to 8.75)

Utility (SF36)^b

0.68 (0.14)

0.66 (0.14)

−0.15 (-0.08 to 0.05)

QALY^b

0.82 (0.12)

0.83 (0.13)

0.01 (-0.6 to 0.07)

Treatment costs

1,969.39 (0)

2,166.84 (0)

197.45

Health care costs^a

1,841.72 (595.12)

1,011.67 (220.68)

−830 (-2,209 to 247)

P & F costs^a

5,347.25 (1229.70)

5,012.60 (1302.51)

−335 (-3,708 to 3,320)

Productivity loss^a

4,002.20 (1484.43)

2,502.57 (1055.98)

−1,500 (-4,987 to 1,907)

Total costs ^a

13,477.71 (2450.28)

10,843.50 (1747.89)

−2,643 (-8,535 to 3,058)